Ticker
MNKDCompany Name
MANNKIND CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Debt | Shareholders Equity | Invested Capital |
---|---|---|---|
6/30/2025 | $ 287.72M | $ -55.04M | $ 232.68M |
3/31/2025 | $ 288.46M | $ -58.62M | $ 229.84M |
12/31/2024 | $ 289M | $ -78.82M | $ 210.18M |
9/30/2024 | $ 481.42M | $ -209.93M | $ 271.5M |
6/30/2024 | $ 470.43M | $ -225.78M | $ 244.65M |
3/31/2024 | $ 509.29M | $ -229.97M | $ 279.32M |
12/31/2023 | $ 512.81M | $ -246.17M | $ 266.64M |
9/30/2023 | $ 381.65M | $ -251.78M | $ 129.87M |
6/30/2023 | $ 383.16M | $ -260.49M | $ 122.67M |
3/31/2023 | $ 382.91M | $ -255.4M | $ 127.51M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Debt + Equity
(=) Inv. Capital
Inv. Capital for MANNKIND CORP is calculated as follows: Debt [ $ 123.35M ] + Equity [ $ -186.42M ]
(=) Inv. Capital [ $ -63.07M ]
Minimum
Sep 30, 2020
Maximum
Mar 31, 2024
Average
Median
filtered constituents | 3.44K |
---|---|
min | $ -1.51B |
max | $ 4.11B |
average | $ 758.9M |
median | $ 302.53M |
std | $ 1B |